Compare SRRK & OMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | OMF |
|---|---|---|
| Founded | 2012 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.9B |
| IPO Year | 2018 | 2013 |
| Metric | SRRK | OMF |
|---|---|---|
| Price | $56.23 | $63.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $56.17 | ★ $66.75 |
| AVG Volume (30 Days) | ★ 981.1K | 952.9K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 7.25% |
| EPS Growth | N/A | ★ 54.72 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $66.43 |
| Revenue Next Year | $534.24 | $6.97 |
| P/E Ratio | ★ N/A | $31.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.07 | $45.78 |
| 52 Week High | $58.49 | $71.93 |
| Indicator | SRRK | OMF |
|---|---|---|
| Relative Strength Index (RSI) | 62.50 | 51.41 |
| Support Level | $45.81 | $62.94 |
| Resistance Level | $58.49 | $66.28 |
| Average True Range (ATR) | 2.38 | 1.35 |
| MACD | 0.63 | -0.37 |
| Stochastic Oscillator | 93.21 | 33.55 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.